News | Boustead Securities

Boustead IPO Client Blue Water Vaccines ("BWV") Announces Closing of Initial Public Offering

Irvine, CA, & Cincinnati, OH — February 23, 2022 – Boustead Securities, LLC (“Boustead”) IPO client Blue Water Vaccines Inc. ("BWV" or...

Irvine, CA, Tokyo, and New York, NY — February 14, 2022 – Boustead Securities, LLC (“Boustead”) IPO client HeartCore Enterprises, Inc.,...

Irvine, CA, Tokyo, and New York, NY — February 9, 2022 – Boustead Securities, LLC (“Boustead”) IPO client HeartCore Enterprises, Inc.,...

Irvine, CA and Toronto, Ontario — February 2, 2021 – Boustead Securities, LLC (“Boustead”) client Newt Corporation (“Newt”or the...

Las Vegas, NV & Irvine, CA – January 28, 2022 – Boustead Securities, LLC (“Boustead”) client Cytta Corp (OTCQB: CYCA, the “Company”) is...

Irvine, CA, January 25, 2021 -- Boustead Securities, LLC ("Boustead") client Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the...

Scottsdale, AZ & Irvine, CA – January 14, 2022 – Boustead Securities, LLC (“Boustead”) client Cerberus Cyber Sentinel Corporation, a...

Irvine, CA, January 6, 2022 -- Boustead Securities, LLC (“Boustead”) client, The Messi Store, aka MGO Global, Inc. (or the “Company”), a...

Hong Kong and New York – December 22, 2021 – Boustead Securities, LLC (“Boustead”) client Ev Dynamics (Holdings) Limited (the "Company"),...